Stockscreener 앱 받기
0.6613
1.35%
0.0042
전일 마감가:
$0.6571
열려 있는:
$0.62
하루 거래량:
5.18M
Relative Volume:
0.77
시가총액:
$21.54M
수익:
$950.10K
순이익/손실:
$-16.69M
주가수익비율:
-0.7967
EPS:
-0.83
순현금흐름:
$-15.16M
1주 성능:
+0.88%
1개월 성능:
+5.70%
6개월 성능:
-42.59%
1년 성능:
-43.32%
1일 변동 폭
$0.61
$0.72
1주일 범위
$0.603
$0.8793
52주 변동 폭
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
명칭
Femasys Inc
전화
770-500-3910
주소
3950 JOHNS CREEK COURT, SUWANEE
FEMY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.6613 | 28.26M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
536.22 | 192.92B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
178.06 | 50.82B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
74.80 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
244.61 | 36.34B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
285.74 | 20.13B | 2.96B | 487.70M | 344.00M | 6.6758 |
Femasys Inc 주식(FEMY)의 최신 뉴스
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing - MSN
Is Femasys Inc. stock a safe haven asset2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
Can Femasys Inc. stock reach $100 price targetMarket Performance Report & AI Enhanced Market Trend Forecasts - newser.com
Femasys surges on Fembloc FDA approval, $58 million funding news | Tap to know more | Inshorts - Inshorts
Is Femasys Inc. stock affected by interest rate hikesJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
FDA approves Femasys to continue pivotal trial for non-surgical birth control - Investing.com Nigeria
Femasys Secures Fda Approval to Advance Final Fembloc Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - MarketScreener
Femasys Inc. announced that it expects to receive $12 million in funding - MarketScreener
Will Femasys Inc. stock benefit from commodity pricesSwing Trade & Free Reliable Trade Execution Plans - newser.com
Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges - MSN
Femasys Receives FDA Approval for FemBloc Trial - TipRanks
Applying Elliott Wave Theory to Femasys Inc.Weekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Femasys Inc Secures FDA Approval for Final FemBloc Trial Phase - TradingView
Femasys secures FDA approval to advance final FemBloc trial phase - TipRanks
Femasys Inc. Advances FemBloc Toward FDA Approval with Successful Trial Completion and $12 Million Financing - Quiver Quantitative
Why Femasys Inc. stock is considered a top pickMarket Movement Recap & Expert Approved Momentum Ideas - newser.com
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, ... - Caledonian Record
Femasys Secures FDA Approval to Advance Final FemBloc® - GlobeNewswire
Exit strategy if you’re trapped in Femasys Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
Is Femasys Inc. forming a bottoming base2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Femasys Meets Nasdaq Equity Requirement After Offering - MSN
Custom watchlist performance reports with Femasys Inc.Earnings Overview Summary & Accurate Buy Signal Notifications - newser.com
Will Femasys Inc. stock continue upward momentum2025 Top Gainers & Daily Price Action Insights - newser.com
What margin trends mean for Femasys Inc. stockTrade Risk Report & Daily Profit Maximizing Tips - newser.com
What to do if you’re stuck in Femasys Inc.Quarterly Investment Review & Free Expert Approved Momentum Trade Ideas - newser.com
Is Femasys Inc. stock positioned well for digital economyPortfolio Update Summary & Consistent Profit Trading Strategies - newser.com
How institutional buying supports Femasys Inc. stockWeekly Stock Report & Risk Managed Investment Strategies - newser.com
Why Femasys Inc. stock is favored by pension fundsTrade Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Combining machine learning predictions for Femasys Inc.Stock Surge & Weekly High Return Stock Opportunities - newser.com
Applying Wyckoff theory to Femasys Inc. stockEarnings Risk Report & High Return Stock Watch Alerts - newser.com
Femasys Inc (FEMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.50%
0.37%
자본화:
|
볼륨(24시간):